» Articles » PMID: 33491313

Adiposity Measures and Morning Serum Cortisol in African Americans: Jackson Heart Study

Overview
Date 2021 Jan 25
PMID 33491313
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Altered hormonal regulation, including cortisol, is a proposed mechanism linking adiposity to obesity-related disorders. We examined the association of anthropometric, adipokine, and body fat distribution measures of adiposity with morning serum cortisol in an African American (AA) cohort.

Methods: We investigated the cross-sectional associations of adiposity measures (BMI, waist circumference, leptin, adiponectin, leptin:adiponectin ratio, subcutaneous and visceral adipose tissue) and liver attenuation with cortisol in the Jackson Heart Study. Linear regression models were used to analyze the association between exposures and cortisol. Models were adjusted for multiple covariates.

Results: Among 4,211 participants, a 1-SD higher BMI and waist circumference were associated with a 3.92% and 3.05% lower cortisol, respectively. A 1-SD higher leptin and leptin:adiponectin ratio were associated with a 6.48% and 4.97% lower morning serum cortisol, respectively. A 1-SD higher subcutaneous adipose tissue was associated with a 4.97% lower cortisol (all P < 0.001). There were no associations of liver attenuation or visceral adipose tissue with cortisol.

Conclusions: Several measures of adiposity are associated with lower morning serum cortisol among AAs, with leptin having the greatest magnitude. Future studies examining the role of morning serum cortisol in the pathway from adiposity to cardiometabolic disease in AAs are warranted.

Citing Articles

Cortisol and cardiometabolic disease: a target for advancing health equity.

Ortiz R, Kluwe B, Lazarus S, Teruel M, Joseph J Trends Endocrinol Metab. 2022; 33(11):786-797.

PMID: 36266164 PMC: 9676046. DOI: 10.1016/j.tem.2022.08.002.


Advancing health equity through integrated biology and population health research: A community-based sample cortisol feasibility and exploratory study.

Ortiz R, Joseph J, Branas C, MacDonald J, Tiako M, Oyekanmi K Compr Psychoneuroendocrinol. 2022; 11:100145.

PMID: 35757172 PMC: 9228000. DOI: 10.1016/j.cpnec.2022.100145.

References
1.
Duclos M, Marquez Pereira P, Barat P, Gatta B, Roger P . Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obes Res. 2005; 13(7):1157-66. DOI: 10.1038/oby.2005.137. View

2.
Hajat A, Diez-Roux A, Franklin T, Seeman T, Shrager S, Ranjit N . Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: the multi-ethnic study of atherosclerosis. Psychoneuroendocrinology. 2010; 35(6):932-43. PMC: 2875317. DOI: 10.1016/j.psyneuen.2009.12.009. View

3.
Badrick E, Kirschbaum C, Kumari M . The relationship between smoking status and cortisol secretion. J Clin Endocrinol Metab. 2006; 92(3):819-24. DOI: 10.1210/jc.2006-2155. View

4.
Reynolds R, Ilyas B, Price J, Fowkes F, Newby D, Webb D . Circulating plasma cortisol concentrations are not associated with coronary artery disease or peripheral vascular disease. QJM. 2009; 102(7):469-75. DOI: 10.1093/qjmed/hcp057. View

5.
Yuksel H, Odabasi A, Demircan S, Koseoglu K, Kizilkaya K, Onur E . Effects of postmenopausal hormone replacement therapy on body fat composition. Gynecol Endocrinol. 2007; 23(2):99-104. DOI: 10.1080/09513590601152177. View